1. Home
  2. ECO vs SUPN Comparison

ECO vs SUPN Comparison

Compare ECO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$90.09

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$41.51

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
SUPN
Founded
2018
2005
Country
Greece
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
ECO
SUPN
Price
$90.09
$41.51
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
★ $69.67
$60.50
AVG Volume (30 Days)
★ 734.1K
723.4K
Earning Date
11-11-2026
10-29-2026
Dividend Yield
★ 10.47%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $392,755,000.00
Revenue This Year
$116.49
$22.95
Revenue Next Year
N/A
$54.39
P/E Ratio
$18.60
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$31.75
$37.54
52 Week High
$100.68
$59.68

Technical Indicators

Market Signals
Indicator
ECO
SUPN
Relative Strength Index (RSI) 57.10 47.61
Support Level $47.47 $40.51
Resistance Level $100.68 $52.30
Average True Range (ATR) 4.32 1.72
MACD -0.93 -0.00
Stochastic Oscillator 29.31 67.43

Price Performance

Historical Comparison
ECO
SUPN

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: